Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Greil

Showing results (211-220 of 483) with videos related to

Pageof 49
Sort By:
British Journal of Haematology|June 26, 2020
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosisFiorenza Barraco, Richard Greil, Raoul Herbrecht, et al.
Critical Reviews in Oncology/Hematology|September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questionsPeter Valent, Günther Gastl, Klaus Geissler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II studyHeinz Ludwig, Zdenek Adam, Roman Hajek, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2018
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatmentSebastian Bachmayer, Gerd Fastner, Andrea Vaszi, et al.
Cancers|November 26, 2022
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant TherapyFalk Roeder, Sabine Gerum, Stefan Hecht, et al.
Cancer Chemotherapy and Pharmacology|November 16, 2018
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individualsGordon T Bolger, Albert Licollari, Amin Tan, et al.
The Lancet Regional Health. Europe|December 20, 2024
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialAlexios Matikas, Andri Papakonstantinou, Sibylle Loibl, et al.
Cancer Letters|September 10, 2008
The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cellsIdo Nevo, Orit Sagi-Assif, Tsipi Meshel, et al.
Frontiers in Neurology|January 8, 2025
Electrotherapy as treatment for chemotherapy-induced peripheral neuropathy - a randomized controlled trialRobert Sassmann, Simon Peter Gampenrieder, Florian Rieder, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Pageof 49

Showing results (211-220 of 483) with videos related to

Sort By:
Pageof 49
British Journal of Haematology|June 26, 2020
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosisFiorenza Barraco, Richard Greil, Raoul Herbrecht, et al.
Critical Reviews in Oncology/Hematology|September 10, 2011
Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: open questionsPeter Valent, Günther Gastl, Klaus Geissler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II studyHeinz Ludwig, Zdenek Adam, Roman Hajek, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 3, 2018
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatmentSebastian Bachmayer, Gerd Fastner, Andrea Vaszi, et al.
Cancers|November 26, 2022
How We Treat Localized Rectal Cancer-An Institutional Paradigm for Total Neoadjuvant TherapyFalk Roeder, Sabine Gerum, Stefan Hecht, et al.
Cancer Chemotherapy and Pharmacology|November 16, 2018
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individualsGordon T Bolger, Albert Licollari, Amin Tan, et al.
The Lancet Regional Health. Europe|December 20, 2024
Benefit from dose-dense adjuvant chemotherapy for breast cancer: subgroup analyses from the randomised phase 3 PANTHER trialAlexios Matikas, Andri Papakonstantinou, Sibylle Loibl, et al.
Cancer Letters|September 10, 2008
The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cellsIdo Nevo, Orit Sagi-Assif, Tsipi Meshel, et al.
Frontiers in Neurology|January 8, 2025
Electrotherapy as treatment for chemotherapy-induced peripheral neuropathy - a randomized controlled trialRobert Sassmann, Simon Peter Gampenrieder, Florian Rieder, et al.
Oncotarget|June 11, 2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclonesThomas Melchardt, Clemens Hufnagl, David M Weinstock, et al.
Pageof 49